European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC)

Actualizado 07/07/2008 22:09:29 CET

For further media information please contact: Gill Markham, Assistant Vice President, Communications Europe, Middle East and Africa, Wyeth Europa, UK, Tel: +44(0)1628-692536, Mobile: +44(0)7770-827753, Emails: markhagl@wyeth.com. Jaimella Espley, Senior Account Manager, Edelman, UK, Tel: +44-(0)207-3047-2115, Mob: +44(0)-7880-681750, Email: jaimella.espley@edelman.com